ALIVUS Q2 : STANDALONE NET PROFIT UP 51.3% AT ₹196.75 CR (YOY), UP 22.9% (QOQ). STRONG (ON 1ST LOOK)

• Revenue up 16.0% at ₹682 Cr YoY, up 6.5% QoQ. • PBT up 50.4% at ₹262 Cr YoY, up 23.4% QoQ. • PBT margin 38.4% vs 29.6% YoY, 33.1% QoQ. • PAT margin 28.8% vs 22.1% YoY, 25.0% QoQ.

Alivus Life Sciences Ltd

Open attachment

← Back to feed